Additional Information for Bcg Vaccine
BCG vaccine, also known as Bacillus Calmette-Guérin vaccine, is a type of immunization used to prevent tuberculosis (TB). It is classified as a drug and biological product and falls under the supply class of Drugs And Biologicals in the supply group of Medical, Dental, And Veterinary Equipment And Supplies.
BCG vaccine is made from a weakened strain of Mycobacterium bovis, a bacterium closely related to the bacteria that cause TB. When administered, the vaccine stimulates the immune system to produce a response against TB, providing protection against the disease.
BCG vaccine is primarily used in countries with a high prevalence of TB, especially in infants and children. It is typically given as a single dose through intradermal injection, usually on the upper arm.
It is important to note that BCG vaccine does not provide complete protection against TB, especially in adults. It is primarily used to prevent severe forms of TB in children, such as TB meningitis and disseminated TB.
As with any vaccine, BCG vaccine may have potential side effects, including local reactions at the injection site, such as redness, swelling, and a small sore. In rare cases, more serious side effects may occur, such as abscess formation or disseminated BCG infection.
It is recommended to consult with a healthcare professional or refer to official guidelines for specific information on the use, administration, and safety of BCG vaccine in your region.
Related Item Names for INC 47120 Bcg Vaccine
NATO Stock Numbers with Item Name 47120 Bcg Vaccine Page 1 of 1
- NDC00052-0601-01
- RNCC: 5 | RNVC: 9 | DAC: 4
- 005260202
- RNCC: 3 | RNVC: 2 | DAC: 4